CAPRION PROTEOMICS ACQUIRES BIOMARKER UNIT FROM PPD
MONTREAL, January 22, 2010 - Caprion Proteomics Inc. announced today that it has acquired from PPD, Inc. (Nasdaq: PPDI) the shares and assets of PPD Biomarker Discovery Sciences, LLC, PPD’s proteomics-based biomarker services division based in Menlo Park, Calif. The acquisition, which closed on December 31, 2009, further strengthens Caprion’s market leadership position in the area of proteomics biomarker services and will also broaden its client portfolio and revenue base. Financial terms of the acquisition were not disclosed.
Caprion will perform existing contractual obligations acquired as part of this acquisition from both Caprion’s facilities in Montreal and from a new facility in Menlo Park that will operate under the name Caprion Proteomics, U.S., LLC.
“We are very pleased to add the solid scientific capabilities, experience and customer relationships of PPD’s biomarker unit to Caprion’s rapidly growing biomarker services business,” said Martin LeBlanc, President and CEO of Caprion. “By acquiring this business, we will expand our capacity and be able to better meet the growing biomarker needs of our current and future clients.”
“This acquisition will be immediately accretive for Caprion both from a financial and strategic standpoint,” said Adam Dolder, Managing Director at Great Point Partners, LP, Caprion’s majority shareholder. “It further positions the Company for continued growth and solidifies its market leadership position in the biomarker space.”
U.S. National Institutes of Health (NIH)
choose Caprion's distinctive, quantitative protein profiling technologies to analyze pathogen and host proteins involved during Brucella (a potential bioterrorism agent) infection.
Details...
News
- March 25, 2009
Caprion article in Genetic Engineering & biotechnology News: "Personalized Medicine Grows in Fits and Starts" March 1st 2009 issue (Volume 29, Number 5)
- December 16, 2008
CAPRION PROTEOMICS INC. ANNOUNCES STRATEGIC MARKETING AND DISTRIBUTION ALLIANCE WITH COVANCE INC.
- December 16, 2008
COVANCE PURCHASES EQUITY STAKE IN CAPRION PROTEOMICS
Events
- February 25 - 26, 2010
The 5th Annual Biomarkers Congress http://www.biomarkers-congress.com/
Manchester, UK
- May 4 - 6, 2010
Biomarker World Congress 2010 http://www.biomarkerworldcongress.com/
Philadelphia, PA, USA